Showing 121-130 of 10577 results for "".
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
https://reachmd.com/programs/neurofrontiers/navigating-ms-diagnosis-in-older-adults-distinguishing-comorbidities-and-mimics/32823/Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the roConfessions of an E-Bay Junkie
https://reachmd.com/programs/clinicians-roundtable/confessions-of-an-e-bay-junkie/1754/Dr. Michael Greenberg welcomes Mitchell Cohen, M.D. as they discuss the pros and cons of shopping on E-Bay, including purchasing medical equipment from the online marketplace.FAERS Data: Three Ways the FDA Makes it Available to the Public
https://reachmd.com/programs/FDA-Drug-Information-Updates/faers-data-three-ways-fda-makes-it-available-public/7463/FAERS is the database that houses reports submitted to FDA on adverse events and medication errors. This database is used by the FDA’s drug and biologic post-marketing safety surveillance program. FDA Drug Info Rounds pharmacists review the three ways FAERS data is made available to the public.” LeInnovations in Less-Invasive Epilepsy Surgery
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/innovations-in-less-invasive-epilepsy-surgery/39963/Recent developments in epilepsy surgery underscore a growing trend toward reduced invasiveness and expanded clinical indications.Physicians For Human Rights: How You Can Get Involved
https://reachmd.com/programs/clinicians-roundtable/physicians-for-human-rights-how-you-can-get-involved/2215/With our special skills, ethical obligations and credible voices, health professionals are in a unique position to be human rights advocates. What is being done and how can you get involved? Past president of the board of directors of Physicians for Human Rights, Dr. Holly Atkinson tells host Dr. LeThe Looming Shortage of General Surgeons
https://reachmd.com/programs/clinicians-roundtable/the-looming-shortage-of-general-surgeons/3225/The largest health problem in our country is a physician shortage, says guest, Dr. George Sheldon, Professor of Surgery at The University of North Carolina. There are 26% fewer surgeons today than in 1998. Why the shortage? In this segment host Dr. Bill Rutenberg explores with our guest many contDetecting Sjögren’s Disease Early: Why Education and Awareness Matters
https://reachmd.com/programs/living-rheum/detecting-sjogrens-disease-early-why-education-and-awareness-matters/36348/Despite progress in reducing diagnostic delays, systemic barriers and limited provider recognition still contribute to missed or late diagnoses of Sjögren’s disease. Because of this, continued outreach and balanced, accessible education remain essential to improving early identification and care. LeThe Social Determinants of Health
https://reachmd.com/programs/primary-care-today/the-social-determinants-of-health/6751/Over the course of his storied career in emergency medicine at the University of Alberta, Dr. Louis Hugo Francescutti has made it his mission to raise awareness of public safety and to promote injury prevention. Moreover, he has also become an internationally recognized figure in preventive care, leKaiser's Cure for Improving Care: Get Integrated
https://reachmd.com/programs/clinicians-roundtable/kaisers-cure-for-improving-care-get-integrated/2793/When it comes to an integrated health care system, Kaiser Permanente has been at the forefront. Dr. Robert Pearl, executive director and CEO of the Permanente Medical Group, tells the Chicago Tribune's Bruce Japsen how integration among doctors and health care facilities——coordinating care at all lePromising results for APOC3 ASO in familial chylomicronemia syndrome
https://reachmd.com/programs/acc-action-center/promising-results-for-apoc3-aso-in-familial-chylomicronemia-syndrome/24309/ACC.24 - Results of the Balance trial showed that the APOC3 ASO olezarsen reduces triglycerides in patients with familial chylomicronemia syndrome (FCS). The data of the secondary outcome of new-onset pancreatitis were quite astonishing, according to Erik Stroes.